Cutera, Inc. Announces First Quarter 2021 Financial Results

Rhea-AI Summary

Cutera (NASDAQ: CUTR) reported strong financial results for Q1 2021, with revenue of $49.7 million, a 54.1% increase year-over-year. Capital equipment revenue rose 35.1% to $28.3 million, while recurring revenue surged 89.2% to $21.3 million, driven by a 324.4% increase in skincare revenue. Gross margin improved to 55.8%, and adjusted EBITDA showed a notable gain of $12.9 million year-over-year, reaching $4.6 million. The net loss decreased to $0.4 million, or $0.02 per share. Despite positive results, management remains cautious due to ongoing COVID-19 uncertainties.

Positive

• Revenue increased by 54.1% to $49.7 million.
• Capital Equipment revenue rose by 35.1% to $28.3 million.
• Recurring revenue grew by 89.2% to $21.3 million.
• Skincare revenue surged by 324.4% to $12.3 million.
• Gross Margin improved to 55.8%, up from 44.5%.
• Adjusted EBITDA improved by $12.9 million year-over-year to $4.6 million.
• Net loss reduced to $0.4 million from $12.4 million.

Negative

• Management did not provide full-year guidance due to COVID-19 uncertainties.

Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2021.

First Quarter 2021 Financial and Operational Highlights

• Revenue was $49.7 million, an increase of 54.1% from the prior-year period, driven by strong performance across the business, with particular strength in capital equipment and skincare sales.
  • Capital Equipment revenue of $28.3 million increased 35.1% over the prior-year period.
  • Recurring revenue, defined by the combination of Skincare, Consumable Products, and Service, was $21.3 million, an increase of 89.2% over the prior-year period:
    • Skincare revenue of $12.3 million increased 324.4% over the prior-year period;
    • Consumable Product revenue of $2.9 million grew 15.5% over prior-year period, reflecting the continued recovery of energy-based treatment volumes; and
    • Service revenue of $6.1 million increased 4.6% over the prior-year period.
• Gross Margin was 55.8%, compared to 44.5% in the prior-year period, due to ongoing improvements in manufacturing efficiencies, offset by mix shift associated with growth of skincare during the quarter;
• Operating Expenses were $26.5 million in the quarter, flat to prior-year period;
• Adjusted EBITDA was $4.6 million in the period as compared to $(8.3) million, a $12.9 million improvement over prior-year period; and
• Net loss was ($0.4) million, or ($0.02) per fully diluted share, compared to a net loss of ($12.4) million, or ($0.86) per fully diluted share, in the prior-year period;
• Announced pricing of offering of $138.3 million of convertible senior notes.

“I am pleased with our first-quarter results, which reflect the continued progress we have made since the onset of the COVID-19 pandemic,” commented Dave Mowry, Chief Executive Officer of Cutera, Inc. “In the first-quarter, we achieved broad strength across our business, driven by consistent execution from our commercial teams, strength in the skincare business, and a slow but steady improvement in our end markets. Building upon the tremendous work from our team, in 2021 we plan to continue to improve gross margins by reducing manufacturing costs; increase sales and sales productivity with our focus on people and process; and deliver innovative products through our increased R&D investments. As we execute these vital few initiatives, our objective is to deliver strong performance despite the remaining pandemic uncertainties that will likely be headwinds for many of us in this market.”

2021 Outlook

Company management remains cautious with the lingering uncertainty related to COVID-19. Global Energy-based Aesthetics end markets continued to improve over the course of the first quarter, but the pace and extent of customer recovery varied by geography. With several geographies still under activity restrictions, management is not issuing full-year guidance at this time.

Conference Call

The Company’s management will host a conference call to discuss these results and related matters today at 1:30 p.m. PT (4:30 p.m. ET). Participating on the call will be Dave Mowry, Chief Executive Officer and Rohan Seth, Chief Financial Officer.

To participate in the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference Code: 13719080.

The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

*Use of Non-GAAP Financial Measures

In this press release, in order to supplement the Company’s condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share. Non-GAAP adjustments include stock-based compensation, depreciation, amortization, executive and other non-recurring separation costs, customer relationship management (“CRM”) and enterprise resource planning (“ERP”) system costs, non-recurring legal and litigation costs, as well as the net tax impact of excluding these items. From time to time in the future, there may be other items that we may exclude if the Company believes that doing so is consistent with the goal of providing useful information to investors and management. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. The Company has not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability, limited visibility, unpredictability, or unique non-recurring nature of the items. Forward-looking non-GAAP measures include adjusted EBITDA. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, executive and other non-recurring separation costs, customer relationship management and enterprise resource planning system costs, and non-recurring legal and litigation costs.

Company management uses these measurements as aids in monitoring the Company’s ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP. Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

Non-cash expenses for stock-based compensation. The Company has excluded the effect of stock-based compensation expenses in calculating its non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to the Company's employees, the Company continues to evaluate its business performance excluding stock-based compensation expenses. The Company records stock-based compensation expense related to grants of options, employee stock purchase plan, and performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods. The Company believes that excluding stock-based compensation better allows for comparisons to its peer companies;

Depreciation and amortization. The Company has excluded depreciation and amortization expense in calculating its non-GAAP operating expenses and net income measures. Depreciation and amortization are non-cash charges to current operations;

Executive and other n

FAQ

What were Cutera's Q1 2021 earnings results?

Cutera reported Q1 2021 revenue of $49.7 million, a 54.1% increase from the prior year, with a net loss of $0.4 million.

How did Cutera's revenue break down for Q1 2021?

In Q1 2021, Cutera's capital equipment revenue was $28.3 million, and recurring revenue was $21.3 million, which included skincare revenue of $12.3 million.

What is Cutera's outlook for 2021?

Management remains cautious regarding the full-year outlook for 2021 due to the lingering uncertainties related to COVID-19.

What improvements did Cutera achieve in gross margin for Q1 2021?

Cutera's gross margin improved to 55.8% in Q1 2021, up from 44.5% in the same period last year.

What was Cutera's adjusted EBITDA for Q1 2021?

Cutera's adjusted EBITDA for Q1 2021 was $4.6 million, representing a year-over-year improvement of $12.9 million.